Clinical TrialsSearch results
Number of results: 865
Other
- Randomized trial of platinum based combination chemotherapy with or without Zoledronic acid as first line therapy for non-small cell lung cancer with bone metastases stratified by bone marker (TORG0706).
- Non-small cell carcinoma
- Thoracic Oncology Research Group (TORG)
- 2009-05-01
Other
- Randomized trial of adjuvant chemotherapy with cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer (JCOG9206-2)
- gastric neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2005-08-18
Other
- randomized trial for the efficacy of primary prophylaxis with granulocyte colony stimulating factor in advanced childhood mature B-cell malignancies
- advanced childhood mature B-cell malignancies
- Japan Pediatric Leukemia/Lymphoma Study Group
- 2007-04-11
Other
- Randomized study of Taxane vs TS-1 in metastatic or recurrent breast cancer patients
- Metastatic or recurrent breast cancer
- SELECT BC executive committee
- 2006-06-01
Other
- Randomized Prospective Trial of Intravesical Bacillus Calmette-Guerin Instillation with Low Dose versus Standard Dose for Transitional Cell Carcinoma of the Urinary Bladder
- Initial or recurrent superficial bladder cancer that cannot be completely resected and carcinoma in situ (CIS) of the bladder.
- Study Group for Low-dose BCG Intravesical Instillation Therapy
- 2007-10-05
Other
- Randomized Phase III Trial of Paclitaxel plus Carboplatin (TC) Therapy versus Irinotecan plus Cisplatin (CPT-P) Therapy as a First Line Chemotherapy for Clear Cell Carcinoma of the Ovary
- clear cell carcinoma of the ovary
- Japanese Gynecologic Oncology Group
- 2006-10-10
Other
- Randomized Phase III Trial of Irinotecan plus Cisplatin vs. bi-weekly Irinotecan after S-1 failure for Patients with Advanced and Recurrent Gastric Cancer
- S-1 failure for Patients with Advanced and Recurrent Gastric Cancer
- The Tokyo cooperative oncology group
- 2008-04-01
Other
- Randomized phase III trial of erlotinib versus docetaxel for patients with previously treated advanced non-small cell lung cancer
- Previously treated non-small cell lung cancer
- National Hospital Organization Headquarters Center for Support and Education of Clinical Research
- 2009-08-11
Other
- Randomized phase III trial of Docetaxel versus docetaxel plus S-1 for second-line treatment of non-small cell lung cancer (NSCLC)
- Advanced non-small cell lung cancer
- The Japan-multinational Trial Organization
- 2009-03-31
Other
- Randomized Phase III Trial of Conventional Paclitaxel and Carboplatin Versus Dose Dense weekly Paclitaxel and Carboplatin in Patients With Newly Diagnosed Stage II-IV Mullerian Carcinoma (Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer)
- Patients with stageII-IV Mullerian Carcinoma (Ovarian Epithelial,Primary Peritoneal,or Fallopian Tube Cancer)
- Japanese Gynecologic Oncology Group
- 2005-09-15